Next Article in Journal
Simultaneous Screening of Major Flame Retardants and Plasticizers in Polymer Materials Using Pyrolyzer/Thermal Desorption Gas Chromatography Mass Spectrometry (Py/TD–GC–MS)
Previous Article in Journal
New Findings in Prunus padus L. Fruits as a Source of Natural Compounds: Characterization of Metabolite Profiles and Preliminary Evaluation of Antioxidant Activity
Article

Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl4-Induced Liver Fibrosis and Necrosis

1
Department of Biomedical Engineering, I-Shou University, Kaohsiung City 82445, Taiwan
2
Hualien Armed Forces General Hospital, Hualien County 97054, Taiwan
3
Department of Culinary Arts, National Kaohsiung University of Hospitality and Tourism, Kaohsiung City 81271, Taiwan
4
Research & Development Department, Biored Technologies Inc., Tainan 70401, Taiwan
5
Department of Electrical Engineering, I-Shou University, Kaohsiung City 82445, Taiwan
6
Department of Veterinary Medicine, National Chiayi University, Chiayi 60054, Taiwan
*
Authors to whom correspondence should be addressed.
Molecules 2018, 23(4), 726; https://doi.org/10.3390/molecules23040726
Received: 6 March 2018 / Revised: 20 March 2018 / Accepted: 21 March 2018 / Published: 22 March 2018
Astaxanthin (Asta), a xanthophyll carotenoid, has been reported to be a strong antioxidative agent and has anti-inflammatory, antitumor and free radical-scavenging activities. However, inadequate stability and water solubility results in its low bioavailability. This study incorporated Asta into hydrophilic hyaluronan nanoparticles (HAn) to produce Asta-HAn aggregates (AHAna) using an electrostatic field system and investigated the restorative effects of AHAna on retrorsine-CCl4-induced liver fibrosis in rats in vivo. Transmission electron microscopy (TEM) revealed that the prepared HAn were approximately 15 ± 2.1 nm in diameter and after the incorporation of Asta into HAn, the size increased to 210–500 nm. The incorporation efficiency of Asta was approximately 93% and approximately 54% of Asta was released after incubation for 18 h. Significant reductions in alanine aminotransferase and aspartate aminotransferase levels were observed after the rats were intraperitoneally injected with AHAna. Histopathological findings revealed the greatest reduction in hepatic fibrosis and hepatocyte necrosis in the rats after 2 weeks of intraperitoneal injection with AHAna, which is consistent with the data acquired from serum biochemical analysis. The restorative effects on liver damage displayed by AHAna in vivo demonstrated that Asta aggregated through HAn incorporation exerts therapeutic effects on liver fibrosis and necrosis. View Full-Text
Keywords: astaxanthin; hyaluronan nanoparticle; astaxanthin-hyaluronan nanoparticles-aggregate; liver fibrosis and necrosis astaxanthin; hyaluronan nanoparticle; astaxanthin-hyaluronan nanoparticles-aggregate; liver fibrosis and necrosis
Show Figures

Figure 1

MDPI and ACS Style

Wu, Y.J.; Wu, Y.C.; Chen, I.-F.; Wu, Y.-L.; Chuang, C.W.; Huang, H.H.; Kuo, S.M. Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl4-Induced Liver Fibrosis and Necrosis. Molecules 2018, 23, 726. https://doi.org/10.3390/molecules23040726

AMA Style

Wu YJ, Wu YC, Chen I-F, Wu Y-L, Chuang CW, Huang HH, Kuo SM. Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl4-Induced Liver Fibrosis and Necrosis. Molecules. 2018; 23(4):726. https://doi.org/10.3390/molecules23040726

Chicago/Turabian Style

Wu, Yi J., Yu C. Wu, I-Fen Chen, Yi-Lung Wu, Chin W. Chuang, Han H. Huang, and Shyh M. Kuo. 2018. "Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl4-Induced Liver Fibrosis and Necrosis" Molecules 23, no. 4: 726. https://doi.org/10.3390/molecules23040726

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop